Replies to post #431092 on NorthWest Biotherapeutics Inc (NWBO)

[Chiugray]

Agree the price can be higher. If we follow a higher-efficacy-drug gets to charge a higher price model (like UK) I would be happy with that too.

On the other hand, I would like Northwest to be the responsible adult in the house, not too greedy.

Most cancer treatments are prohibitively expensive. As for the expected cost of DCVAX-L, judging from talking with people who have previously undergone treatment in the UK, I believe t it is possible that DCVAX-L might be priced at half the cost of the approved immune therapies offered by Big Pharma.

https://www.heraldtribune.com/story/business/2021/12/30/joan-lappin-biotech-firm-nwbo-gets-uk-approval-special-treatment/9025652002/